Mountain Company Profile
What is the competitive landscape for MOUNTAIN
MOUNTAIN has four approved drugs.
Summary for Mountain
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Mountain
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mountain | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | TABLET;ORAL | 040537-001 | Sep 30, 2003 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mountain | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 091159-003 | Mar 12, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mountain | METAXALONE | metaxalone | TABLET;ORAL | 040486-001 | Feb 27, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mountain | GRISEOFULVIN, ULTRAMICROSIZE | griseofulvin, ultramicrosize | TABLET;ORAL | 204371-002 | Jan 9, 2014 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
